Investigators and Staff
SPORE Leaders
Principal Investigator
Hagop M. Kantarjian, M.D.
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd., Box 428
Houston, TX 77030
Office: 713-792-7026
FAX: 713-794-4297
E-mail: hkantarjian@mdanderson.org
Co-Principal Investigator
Jean-Pierre Issa, M.D.
Temple University
Fels Institute
PAHB Room 154
3307 N. Broad Street
Philadelphia, Pa. 19140
Office: 215-707-4307
E-mail: jpissa@temple.edu
SPORE Project Leaders
Project 1: Epigenetics and Epigenetic Therapy in AML
Co-Project Leader, Basic Research
Jean-Pierre Issa, M.D.
Temple University
Fels Institute
PAHB Room 154
3307 N. Broad Street
Philadelphia, Pa. 19140
Office: 215-707-4307
E-mail: jpissa@temple.edu
Co-Project Leader, Clinical Research
Hagop M. Kantarjian, M.D.
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd., Box 428
Houston, TX 77030
Office: 713-792-7026
FAX: 713-794-4297
E-mail: hkantarjian@mdanderson.org
Project 2: Adoptive Cellular Therapy for Myeloid Leukemia
Co-Project Leader, Basic Research
Jeffrey Molldrem, M.D.
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd., Box 448
Houston, TX 77030
Office: 713-563-3318
FAX: 713-563-3364
E-mail: jmolldre@mdanderson.org
Co-Project Leader, Clinical Research
Richard Champlin, M.D.
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd., Box 423
Houston, TX 77030
Office: 713-792-3618
FAX: 713-792-4346
E-mail: rchampli@mdanderson.org
Project 3: P53 Activation as Novel Therapeutic Strategy for Acute Myelogenous Leukemia
Co-Project Leader, Basic Research
Michael Andreeff, M.D., Ph.D.
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd., Box 448
Houston, TX 77030
Office: 713-792-7260
FAX: 713-794-4747
E-mail: mandreef@mdanderson.org
Co-Project Leader, Clinical Research
Marina Konopleva, M.D., Ph.D.
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd., Box 428
Houston, TX 77030
Office: 713-794-1628
E-mail: mkonople @mdanderson.org
Co-Project Leader
Kensuke Kojima, Ph.D.
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd., Box 448
Houston, TX 77030
Office: 713-794-5644
E-mail: kkojima @mdanderson.org
Project 4: Incorporating FLT3 Inhibitors into AML Treatment Regimens
Project Leader, Basic Research
Mark Levis, M.D., Ph.D.
Johns Hopkins University School of Medical Oncology Center
1650 Orleans Street, Room 243
Baltimore, MD 21231
Office: (410) 502-3629
FAX: (410) 614-7279
E-mail: levisma@jhmi.edu
Co-Project Leader
Donald Small, M.D., Ph.D.
Johns Hopkins University School of Medical Oncology Center
CRB Room 251, 1650 Orleans St.
Baltimore, MD 21231
Office: (410) 614-0994
FAX: (410) 955-8897
E-mail: donsmall@jhmi.edu
Project 5: Development of Sapacitabine Therapy in Leukemias
Project Leader
William Plunkett Ph.D.
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd., Box1950
Houston, TX 77030
Office: 713-792-3335
E-mail: wplunket @mdanderson.org
Co-Project Leader
Hagop M. Kantarjian, M.D.
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd., Box 428
Houston, TX 77030
Office: 713-792-7026
FAX: 713-794-4297
E-mail: hkantarjian@mdanderson.org
SPORE Core Leaders
Core A: Administrative Core
Leader
Hagop M. Kantarjian, M.D.
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd., Box 428
Houston, TX 77030
Office: 713-792-7026
FAX: 713-794-4297
E-mail: hkantarjian@mdanderson.org
Co-Leader
Jean-Pierre Issa, M.D.
Temple University
Fels Institute
PAHB Room 154
3307 N. Broad Street
Philadelphia, Pa. 19140
Office: 215-707-4307
E-mail: jpissa@temple.edu
Core B: Pathology and Tissue Core
Leader
Steven Kornblau, M.D.
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd., Box 448
Houston, TX 77030
Office: 713-794-1568
FAX: 713-794-1938
E-mail: smkornbl@mdanderson.org
Co-Leader
Jean-Pierre Issa, M.D.
Temple University
Fels Institute
PAHB Room 154
3307 N. Broad Street
Philadelphia, Pa. 19140
Office: 215-707-4307
E-mail: jpissa@temple.edu
Co-Leader
Carlos Bueso-Ramos, M.D.
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd., Box 72
Houston, TX 77030
Office: 713-563-1091
E-mail: cbuesora@mdanderson.org
Core C: Biostatistics and Data Management Core
Leader
Donald Berry, Ph.D.
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd., Box 1411
Houston, TX 77030
Office: 713-794-4141
FAX: 713-745-4940
E-mail: dberry@mdanderson.org
Co-Leader
Xuelin Huang, Ph.D.
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd., Box 1411
Houston, TX 77030
Office: 713-794-4172
E-mail: xlhuang@mdanderson.org
SPORE Program Leaders
Developmental Research Program
Director
Jean-Pierre Issa, M.D.
Temple University
Fels Institute
PAHB Room 154
3307 N. Broad Street
Philadelphia, Pa. 19140
Office: 215-707-4307
E-mail: jpissa@temple.edu
Co-Director
Hagop M. Kantarjian, M.D.
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd., Box 428
Houston, TX 77030
Office: 713-792-7026
FAX: 713-794-4297
E-mail: hkantarjian@mdanderson.org
Career Development Program
Director
Hagop M. Kantarjian, M.D.
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd., Box 428
Houston, TX 77030
Office: 713-792-7026
FAX: 713-794-4297
E-mail: hkantarjian@mdanderson.org
Co-Director
Jean-Pierre Issa, M.D.
Temple University
Fels Institute
PAHB Room 154
3307 N. Broad Street
Philadelphia, Pa. 19140
Office: 215-707-4307
E-mail: jpissa@temple.edu